# 1. Financial Performance ## A. Key Figures * **Revenue (Q4):** **₹1,348.6 Cr** (+2.4% YoY / +0.1% QoQ) · **$145.3 M** (-3.7% QoQ CC) * **Revenue (FY26):** **₹5,310 Cr** (-1.2% YoY) · **$597.5 M** (-6.0% YoY) * **EBITDA Margin:** **18.5%** Q4 (+30 bps QoQ) · **16.3%** FY26 (+333 bps YoY) * **Cash & Liquidity:** **₹2,637.3 Cr** Cash Balance (+19% YoY) · **62 Days** DSO ## B. Revenue & Growth * **Strategic Rationalization:** Full-year top-line contraction was driven by a deliberate exit from **non-strategic, low-margin streams**, which impacted growth by approximately **200 basis points**. * **Macro & Operational Headwinds:** Recent performance was dampened by soft discretionary spending, fewer working days, and a specific operational issue at a single customer site. * **AI Deal Dynamics:** Revenue was further pressured by upfront productivity pass-throughs associated with new AI-focused contracts. * **Growth Trajectory:** The company has faced stagnant or declining sequential growth for six consecutive quarters, a trend management characterized as disappointing. ## C. Margins & Profitability * **Structural Efficiency:** Significant annual margin expansion was achieved through the rationalization of unprofitable tail accounts and optimized cost structures. * **One-off Tailwinds:** Q4 margins benefited from a **340-basis point** boost, split equally between forex gains and internal one-offs like lower performance-based pay and executive exit-related savings. * **Tax & Regulatory Impacts:** Reported annual PAT was weighed down by **Labor Code changes** and **D. S. federal tax provisions**, though ETR is expected to normalize in FY27. * **Reinvestment Strategy:** Operating leverage gained over the last four quarters is being redirected to fund the sales organization and AI capabilities. ## D. Cash Flow & Capital Allocation * **Strong Liquidity Position:** The firm maintains a robust balance sheet, generating approximately **₹500 Cr** in annual cash flow after taxes and working capital. * **Shareholder Returns:** Total dividend for the year stood at **₹6.50 per share**; management noted the payout remained consistent with PAT levels. * **Capital Deployment:** The Board is currently evaluating the high cash reserves for future allocation, though no specific timeline for increased return on capital has been established. --- # 2. Deal Wins & Pipeline ## A. Key Figures * **Total Deal TCV:** **$208 Million** Q4 FY26 (+3% QoQ) * **Order Book Mix:** **38%** Annual bookings from new/net new business * **Sales Force Expansion:** **30% to 40%** YoY increase in personnel by mid-FY27 ## B. Deal Momentum & Pipeline * **Sustained Booking Levels:** Total contract value maintained a robust trajectory, exceeding the **$200 million** mark for the second consecutive quarter. * **Booking Quality:** While overall TCV remains strong, net new bookings were characterized as softer, with the business model currently absorbing necessary sales ramp-up costs. * **Growth Lag:** Management anticipates a gestation period for new sellers to build and convert pipelines before incremental bookings translate into revenue growth. ## C. AI-Led Engagements * **Strategic Pivot:** The organization is prioritizing "AI First" capabilities, securing marquee projects in the U.S. P&C insurance, asset management, and payments sectors. * **Operational Focus:** Despite a challenging demand environment, the company is leveraging AI orchestration layers and domain expertise to drive operational efficiencies and H2 deal wins. ## D. Sales Force Expansion * **Aggressive Talent Acquisition:** A significant headcount increase in the sales force is underway, targeting a **40%** expansion by Q2 FY26 to catalyze a return to sustainable QoQ growth. * **Resource Reallocation:** Investment in front-end sales and client acquisition is being funded in part by streamlining General and Administrative (G&A) expenses. * **Leadership Strengthening:** The recruitment of new leaders in Q1 and Q2 is focused on expanding the footprint within existing accounts and accelerating new client acquisition. --- # 3. Headcount & Leadership ## A. Management Restructuring * **Strategic Leadership Overhaul:** Appointed **Vikram Puranik** as COO to lead engineering and delivery, alongside new heads for Data/AI, ERP, and Lifesciences to drive the FY 2027 growth strategy. * **Corrective Restructuring:** Management initiated a second round of leadership changes across sales and delivery after previous hires failed to deliver expected results. * **Tier 1 Talent Acquisition:** Recruited high-caliber leadership from top-tier competitors, including a **25-year SAP veteran** based in New York to stabilize and revive the ERP vertical. * **Regional Leadership Strengthening:** Bolstered the Americas business with the induction of **Komal Jain** and established a new Global Partnerships lead in San Francisco. ## B. Talent & Utilization * **Sales Capacity Expansion:** Plans to aggressively expand sales teams across the --- # 4. Vertical & Geography Mix ## A. Key Figures * **Revenue Growth (CC):** **-6.5%** Full Year (Strategic exits/Productivity benefits) * **Energy & Utilities Growth:** **1.8%** Sequential (Sole growing vertical) ## B. Segment Performance * **Vertical Divergence:** Energy & Utilities remains the primary growth engine, while Manufacturing defied expectations of a flat quarter to post continued gains. * **Strategic Revenue Rationalization:** Annual top-line contraction reflects a deliberate exit from **unprofitable accounts** and the impact of upfront productivity commitments in AI-driven deals. * **Recovery Outlook:** Management signals that Life Sciences and MedTech have likely bottomed out, with focused investments planned to stabilize these previously underperforming segments. * **BFSI Niche Strategy:** Performance saw a seasonal dip due to **fewer working days** in the T&M model; however, the strategy remains focused on high-growth subsectors: **payments, asset management, and P&C insurance**. ## C. Client Tier Concentration * **Top-Tier Stabilization:** Stagnation in the top 5 client bucket is categorized as seasonal rather than structural, with a return to growth anticipated. * **Diversification Mandate:** Strategic pivot toward the **"next 5" and "next 10"** client tiers to reduce concentration risk and broaden the revenue base. --- # 5. Service Line Performance ## A. ERP & Data Services * **Resilient ERP Demand:** Management maintains a positive long-term outlook for SAP and JDE platforms, countering broader industry concerns regarding AI-driven effort compression. * **Leadership Reinvestment:** Strategic turnaround efforts are being supported by the acquisition of specialized leadership talent across the Data, AI, and ERP business segments. ## B. AI & Cogito Platform * **Flagship AI Deployment:** The proprietary Cogito platform is driving high-value engagements, notably a data modernization and Agentic AI program for a **Fortune 500** MedTech client. * **Sector-Specific Scaling:** Gen AI services are gaining traction in the North American P&C insurance market for submission processing and across multi-domain transformations in MedTech. * **Operating Model Pivot:** The firm is transitioning to an "AI First" delivery framework to automate internal processes and enhance client decision-making capabilities. ## C. Managed Services Transition * **Shift in Deal Architecture:** Future growth is being anchored in a transition toward outcome-based and managed services engagements. * **Fixed-Price Evolution:** New contract structures are increasingly moving toward fixed-price models where fees are tied to the delivery of specific operational results. --- # 6. Client & Demand Risks ## A. Macroeconomic Headwinds * **Demand Volatility:** Performance was impacted by a soft demand environment, trade tariffs, and geopolitical uncertainty, resulting in revenue falling short of internal expectations. * **Sectoral Recovery:** Management indicates that headwinds in the **Manufacturing and Medical Devices** sectors have likely bottomed out, with operational issues now largely resolved. * **Deal Slippage:** Softness in quarterly net new TCV is attributed to delayed client decision-making rather than competitive losses, with expectations for conversion in **Q1**. * **Spending Pivot:** While total client budgets remain stable, there is a notable structural shift in spending away from traditional services toward **AI-related and new-age work**. * **Competitive Landscape:** Intensity has heightened as Tier-1 players increasingly bid for mid-sized deals, forcing a strategic pivot toward outcome-based offerings and AI investments. ## B. Client-Specific Erosion * **MedTech Impact:** A localized operational failure with a specific client caused significant revenue erosion within the **Life Sciences** vertical. * **Stabilization Outlook:** Leadership anticipates entering FY27 with the majority of client-specific headwinds neutralized, contingent on stable market conditions. ## C. Revenue Deflation Risks * **AI-Driven Deflation:** The transition to AI-infused contracts is creating immediate revenue pressure as the company must underwrite and commit to **upfront productivity savings** for clients. --- # 7. Guidance & Outlook ## A. Key Figures * **Steady-State EBITDA Margin:** **15% range** consistent target · **15% plus** sustainable outlook * **Current EBITDA Margin:** **18.5%** Q4 performance ## B. FY27 Growth Strategy * **Strategic Pivot:** Management has shifted focus from margin expansion toward a **growth-oriented posture**, prioritizing investments in sales and leadership to drive long-term organic revenue. * **Operational De-risking:** Leadership is focused on correcting internal input parameters to ensure historical headwinds are mitigated, though specific top-line guidance remains withheld due to market volatility. ## C. Margin Sustainability * **Planned Margin Compression:** While currently performing significantly above steady-state targets, margins are expected to normalize as the company reinvests excess spread into **service line partnerships and an AI orchestration layer**. * **Normalization of Earnings:** Future margin expectations exclude recent one-off gains; management confirmed that specific **non-recurring factors** impacting previous periods will not repeat in Q1 and beyond. ## D. Order Book Targets * **Back-Ended Seasonality:** Order bookings are projected to follow historical cycles, characterized by a softer first half followed by **stronger H2 performance**. * **Pipeline Ambition:** The company is targeting an order book for **FY26** that is **substantially better** than the previous fiscal year to bolster the conversion pipeline. * **Short-Term Caution:** Management is refraining from committing to specific **Q1 growth targets** given high macro uncertainty, focusing instead on driving the order book and pipeline expansion.